These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 18571396)

  • 1. Canada's new federal 'National Anti-Drug Strategy': an informal audit of reported funding allocation.
    Debeck K; Wood E; Montaner J; Kerr T
    Int J Drug Policy; 2009 Mar; 20(2):188-91. PubMed ID: 18571396
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Moral regulation and the presumption of guilt in Health Canada's medical cannabis policy and practice.
    Lucas P
    Int J Drug Policy; 2009 Jul; 20(4):296-303. PubMed ID: 19124233
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Australian governments' spending on preventing and responding to drug abuse should target the main sources of drug-related harm and the most cost-effective interventions.
    McDonald D
    Drug Alcohol Rev; 2011 Jan; 30(1):96-100. PubMed ID: 21219503
    [TBL] [Abstract][Full Text] [Related]  

  • 4. What drug policies cost: drug policy spending in the Netherlands in 2003.
    Rigter H
    Addiction; 2006 Mar; 101(3):323-9. PubMed ID: 16499504
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The size and mix of government spending on illicit drug policy in Australia.
    Moore TJ
    Drug Alcohol Rev; 2008 Jul; 27(4):404-13. PubMed ID: 18584391
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Drug policy in Canada--the way forward.
    Kerr T; O'Briain W
    Can HIV AIDS Policy Law Rev; 2002 Jul; 7(1):1, 27-32. PubMed ID: 14765475
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Canada's 2003 renewed drug strategy--an evidence-based review.
    DeBeck K; Wood E; Montaner J; Kerr T
    HIV AIDS Policy Law Rev; 2006 Dec; 11(2-3):1, 5-12. PubMed ID: 17373058
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reducing the harm of "harm reduction".
    Beirness DJ; Notarandrea R; Jesseman R; Perron M
    Clin Pharmacol Ther; 2008 Apr; 83(4):523-5. PubMed ID: 18349874
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Setting goals for drug policy: harm reduction or use reduction?
    Caulkins JP; Reuter P
    Addiction; 1997 Sep; 92(9):1143-50. PubMed ID: 9374012
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A review of drug prevention system development in Romania and its impact on youth drug consumption trends, 1995-2005.
    Dégi CL
    Drug Alcohol Rev; 2009 Jul; 28(4):419-25. PubMed ID: 19594796
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Conservative government announces new anti-drug strategy.
    Symington A
    HIV AIDS Policy Law Rev; 2007 Dec; 12(2-3):27-8. PubMed ID: 18459197
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Casting light on harm reduction: introducing two instruments for analysing contradictions between harm reduction and 'non-harm reduction'.
    Jourdan M
    Int J Drug Policy; 2009 Nov; 20(6):514-20. PubMed ID: 19349155
    [TBL] [Abstract][Full Text] [Related]  

  • 13. How much can treatment reduce national drug problems?
    Reuter P; Pollack H
    Addiction; 2006 Mar; 101(3):341-7. PubMed ID: 16499507
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Understanding post 9/11 drug control policy and politics in Central Asia.
    Latypov A
    Int J Drug Policy; 2009 Sep; 20(5):387-91. PubMed ID: 19121928
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The implicit rules of evidence-based drug policy: a U.S. perspective.
    MacCoun R; Reuter P
    Int J Drug Policy; 2008 Jun; 19(3):231-2; discussion 233-4. PubMed ID: 18424113
    [No Abstract]   [Full Text] [Related]  

  • 16. A new National Women's Health Policy: legal, ethical and policy initiatives to support women's health.
    Bennett B
    J Law Med; 2009 Aug; 17(1):9-15. PubMed ID: 19771981
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The contribution of research to the development of a national cannabis policy in Australia.
    Hall WD
    Addiction; 2008 May; 103(5):712-20. PubMed ID: 18412748
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Harm reduction programmes in the Asia--Pacific Region.
    Reid G; Devaney ML; Baldwin S
    Drug Alcohol Rev; 2008 Jan; 27(1):95-8. PubMed ID: 18034387
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Harm reduction: roads less travelled to the holy grail.
    Roche AM; Evans KR; Stanton WR
    Addiction; 1997 Sep; 92(9):1207-12. PubMed ID: 9374022
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cannabis policy in Australia and New Zealand.
    Abel S
    Drug Alcohol Rev; 1997 Dec; 16(4):421-8. PubMed ID: 16203457
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.